CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea
· Delayed Price · Currency is KRW
1,804.00
+14.00 (0.78%)
Apr 29, 2026, 3:30 PM KST
CMG Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 264,638 | 274,691 | 245,561 | 334,730 | 298,618 | 590,292 | |
| Market Cap Growth | -2.29% | 11.86% | -26.64% | 12.09% | -49.41% | 28.01% | |
| Enterprise Value | 310,143 | 305,502 | 239,371 | 285,069 | 182,746 | 466,997 | |
| Last Close Price | 1790.00 | 1858.00 | 1768.00 | 2410.00 | 2150.00 | 4250.00 | |
| PE Ratio | - | - | 91.13 | 51.85 | - | 193.46 | |
| PS Ratio | 2.51 | 2.61 | 2.48 | 3.56 | 3.63 | 10.07 | |
| PB Ratio | 1.31 | 1.36 | 1.30 | 1.76 | 1.62 | 3.28 | |
| P/TBV Ratio | 1.35 | 1.40 | 1.33 | 1.82 | 1.64 | 3.30 | |
| P/OCF Ratio | - | - | 846.50 | 84.99 | 60.48 | 209.07 | |
| EV/Sales Ratio | 2.95 | 2.90 | 2.42 | 3.04 | 2.22 | 7.97 | |
| EV/EBITDA Ratio | - | - | 54.82 | 50.96 | 34.71 | 99.16 | |
| EV/EBIT Ratio | - | - | 234.60 | 93.87 | 61.30 | 179.35 | |
| Debt / Equity Ratio | 0.36 | 0.36 | 0.42 | 0.14 | 0.04 | 0.00 | |
| Debt / EBITDA Ratio | - | - | 18.31 | 4.67 | 1.27 | 0.06 | |
| Net Debt / Equity Ratio | 0.23 | 0.23 | 0.02 | -0.22 | -0.38 | -0.66 | |
| Net Debt / EBITDA Ratio | -74.55 | -74.55 | 0.73 | -7.63 | -13.50 | -25.33 | |
| Net Debt / FCF Ratio | -1.12 | -1.12 | -0.11 | 5.06 | 20.64 | 22.29 | |
| Asset Turnover | 0.35 | 0.35 | 0.36 | 0.41 | - | 0.38 | |
| Inventory Turnover | 1.66 | 1.66 | 2.41 | 2.40 | - | 3.38 | |
| Quick Ratio | 0.60 | 0.60 | 1.46 | 3.80 | 4.58 | 15.12 | |
| Current Ratio | 0.92 | 0.92 | 1.81 | 4.72 | 6.17 | 16.18 | |
| Return on Equity (ROE) | -5.15% | -5.15% | 1.42% | 3.44% | - | 2.15% | |
| Return on Assets (ROA) | -0.76% | -0.76% | 0.23% | 0.83% | - | 1.06% | |
| Return on Invested Capital (ROIC) | -1.53% | -1.68% | 0.56% | 2.23% | 3.41% | 3.74% | |
| Return on Capital Employed (ROCE) | -1.80% | -1.80% | 0.40% | 1.40% | 1.60% | 1.40% | |
| Earnings Yield | -3.81% | -3.67% | 1.10% | 1.93% | -0.13% | 0.52% | |
| FCF Yield | -15.36% | -14.80% | -11.32% | -2.52% | -1.15% | -0.91% | |
| Payout Ratio | - | - | - | 0.45% | - | - | |
| Buyback Yield / Dilution | 73.29% | 73.29% | -288.03% | - | -14.27% | -11.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.